PMC:7275137 / 111-594
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T2 | 3-11 | Body_part | denotes | Lysosome | http://purl.org/sig/ont/fma/fma63836 |
| T3 | 99-107 | Body_part | denotes | Lysosome | http://purl.org/sig/ont/fma/fma63836 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T2 | 192-239 | Disease | denotes | severe acute respiratory syndrome coronavirus-2 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T3 | 192-225 | Disease | denotes | severe acute respiratory syndrome | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T2 | 3-11 | http://purl.obolibrary.org/obo/GO_0005764 | denotes | Lysosome |
| T3 | 99-107 | http://purl.obolibrary.org/obo/GO_0005764 | denotes | Lysosome |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T1 | 144-149 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
| T2 | 172-187 | Chemical | denotes | antiviral drugs | http://purl.obolibrary.org/obo/CHEBI_36044 |
| T3 | 172-181 | Chemical | denotes | antiviral | http://purl.obolibrary.org/obo/CHEBI_22587 |
| T4 | 182-187 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
| T5 | 263-268 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
| T6 | 361-371 | Chemical | denotes | macrolides | http://purl.obolibrary.org/obo/CHEBI_25106 |
| T7 | 378-390 | Chemical | denotes | azithromycin | http://purl.obolibrary.org/obo/CHEBI_2955 |
| T8 | 393-430 | Chemical | denotes | non-steroidal anti-inflammatory drugs | http://purl.obolibrary.org/obo/CHEBI_35475 |
| T9 | 407-430 | Chemical | denotes | anti-inflammatory drugs | http://purl.obolibrary.org/obo/CHEBI_35472 |
| T10 | 425-430 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
LitCovid-PD-GO-BP
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 70-95 | http://purl.obolibrary.org/obo/GO_1903901 | denotes | inhibit viral replication |
| T2 | 78-95 | http://purl.obolibrary.org/obo/GO_0019079 | denotes | viral replication |
| T3 | 78-95 | http://purl.obolibrary.org/obo/GO_0019058 | denotes | viral replication |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T3 | 0-483 | Sentence | denotes | • Lysosome targeting agents can disrupt endolysosomal maturation and inhibit viral replication • Lysosome targeting agents and lysosomotropic drugs should be explored as antiviral drugs for severe acute respiratory syndrome coronavirus-2 • Some lysosomotropic drugs are commonly used pharmacological agents • Particular attention should be directed towards macrolides (e.g. azithromycin), non-steroidal anti-inflammatory drugs (e.g. indomethacin) and other lysosomotoropic agents |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 5 | 361-371 | Chemical | denotes | macrolides | MESH:D018942 |
| 6 | 378-390 | Chemical | denotes | azithromycin | MESH:D017963 |
| 7 | 437-449 | Chemical | denotes | indomethacin | MESH:D007213 |